NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NGNE NEUROGENE INC

盘前交易 12-29 07:51:39 EST

20.01

-0.06

-0.30%

最高20.13	最低19.63	成交量5.96万
今开20.04	昨收20.07	日振幅2.49%
总市值3.10亿	流通市值1.20亿	总股本1,549万
成交额118.78万	换手率0.99%	流通股本601.75万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":20.01,"timestamp":1766782800000,"preClose":20.07,"halted":0,"volume":59618,"delay":0,"floatShares":6017500,"shares":15489800,"eps":-4.120047,"marketStatus":"盘前交易","change":-0.06,"latestTime":"12-29 07:51:39 EST","open":20.04,"high":20.13,"low":19.63,"amount":1187824.26256,"amplitude":0.024913,"askPrice":22.89,"askSize":100,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.120047,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767018600000},"marketStatusCode":1,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":20.01,"postHourTrading":{"tag":"盘后","latestPrice":20.01,"preClose":20.01,"latestTime":"16:58 EST","volume":26,"amount":507.36,"timestamp":1766786287198},"volumeRatio":0.3400679928504182,"impliedVol":0.4238,"impliedVolPercentile":0.0201},"requestUrl":"/m/hq/s/NGNE","defaultTab":"news","newsList":[{"id":"1116676866","title":"NEUROGENE第三季度每股收益为-0.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116676866","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116676866?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:47","pubTimestamp":1763574422,"startTime":"0","endTime":"0","summary":"11月13日 - Neurogene第三季度净收入为-2095.3万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"1185632759","title":"NEUROGENE INC 发布关于脆性X综合征Ngn-401基因疗法试验中儿童组的积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1185632759","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185632759?lang=zh_cn&edition=full","pubTime":"2025-11-13 05:02","pubTimestamp":1762981329,"startTime":"0","endTime":"0","summary":"NEUROGENE INC 发布关于脆性X综合征Ngn-401基因疗法试验中儿童组的积极中期数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2582346146","title":"Neurogene Inc.盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582346146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582346146?lang=zh_cn&edition=full","pubTime":"2025-11-12 02:22","pubTimestamp":1762885346,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时22分，Neurogene Inc.股票出现异动，股价快速上涨5.30%。截至发稿，该股报29.80美元/股，成交量4.5531万股，换手率0.32%，振幅7.35%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为1.50%。其相关个股中，Engene Holdings Inc C/Wts 31/10/2028  Cl A、Engene Holdings Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Salarius Pharmaceuticals, Inc.、Galecto, Inc.较为活跃，换手率分别为2848.22%、438.59%、395.40%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Quoin Pharmaceuticals Ltd、Engene Holdings Inc.，振幅分别为75.38%、64.25%、54.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120222279762fd42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120222279762fd42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"1191399816","title":"Neurogene 宣布 Embolden™ 注册试验中首名参与者接受 Ngn-401 基因治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1191399816","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191399816?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:34","pubTimestamp":1762432448,"startTime":"0","endTime":"0","summary":"Neurogene 宣布 Embolden™ 注册试验中首名参与者接受 Ngn-401 基因治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2581741251","title":"Neurogene Inc.盘中异动 早盘股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581741251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581741251?lang=zh_cn&edition=full","pubTime":"2025-11-04 23:30","pubTimestamp":1762270204,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日23时30分，Neurogene Inc.股票出现异动，股价快速拉升5.96%。截至发稿，该股报32.91美元/股，成交量2.3238万股，换手率0.16%，振幅4.86%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Artelo Biosciences, Inc.、Abpro Holdings, Inc、Biomx Inc.较为活跃，换手率分别为286.22%、106.02%、70.17%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rani Therapeutics Holdings, Inc.，振幅分别为36.51%、31.79%、25.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104233004a6e0d137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104233004a6e0d137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2579818427","title":"Neurogene Inc.盘中异动 大幅上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579818427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579818427?lang=zh_cn&edition=full","pubTime":"2025-10-30 01:23","pubTimestamp":1761758600,"startTime":"0","endTime":"0","summary":"北京时间2025年10月30日01时23分，Neurogene Inc.股票出现异动，股价快速上涨5.37%。截至发稿，该股报32.69美元/股，成交量3.8457万股，换手率0.27%，振幅6.50%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Purple Biotech Ltd、Ernexa Therapeutics Inc.涨幅较大，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Aditxt, Inc.较为活跃，换手率分别为3999.21%、2510.88%、406.04%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Purple Biotech Ltd、Ernexa Therapeutics Inc.，振幅分别为139.33%、93.83%、91.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030012320a47c3998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030012320a47c3998&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2574116247","title":"Neurogene Inc.盘中异动 早盘大幅拉升5.54%报27.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574116247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574116247?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:35","pubTimestamp":1760016951,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时35分，Neurogene Inc.股票出现波动，股价急速拉升5.54%。截至发稿，该股报27.26美元/股，成交量1.095万股，换手率0.08%，振幅2.75%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Turn Therapeutics Inc.、Galecto, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1624.50%、935.11%、641.98%，振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Adaptimmune Therapeutics Plc，振幅分别为62.86%、22.06%、19.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213551a458615f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213551a458615f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"1182799508","title":"Neurogene公布Ngn-401基因疗法治疗雷特综合征的积极监管进展，计划于2025年第四季度启动Embolden™注册试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1182799508","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182799508?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:30","pubTimestamp":1760009442,"startTime":"0","endTime":"0","summary":"Neurogene公布Ngn-401基因疗法治疗雷特综合征的积极监管进展，计划于2025年第四季度启动Embolden™注册试验给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"1127808984","title":"NEUROGENE INC宣布根据纳斯达克上市规则发放引导激励赠款","url":"https://stock-news.laohu8.com/highlight/detail?id=1127808984","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127808984?lang=zh_cn&edition=full","pubTime":"2025-10-04 04:12","pubTimestamp":1759522322,"startTime":"0","endTime":"0","summary":"10月3日 - NEUROGENE INC宣布根据纳斯达克上市规则5635(C)(4)发放引导激励赠款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2555940170","title":"Neurogene Inc.7月29日成交额为386.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555940170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555940170?lang=zh_cn&edition=full","pubTime":"2025-07-30 12:33","pubTimestamp":1753849989,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Neurogene Inc.成交额为386.34万美元，成交额较昨日增加123.76%，当日成交量为18.26万股。Neurogene Inc.于2025年7月29日跌3.14%，报21.0美元，该股过去5个交易日跌4.28%，年初至今跌8.14%，过去60日涨36.36%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730123312a6c8f92c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730123312a6c8f92c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2555081107","title":"Neurogene Inc.7月28日成交额为172.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555081107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555081107?lang=zh_cn&edition=full","pubTime":"2025-07-29 12:30","pubTimestamp":1753763436,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Neurogene Inc.成交额为172.66万美元，成交额较昨日增加0.48%，当日成交量为7.83万股。Neurogene Inc.于2025年7月28日跌4.58%，报21.68美元，该股过去5个交易日涨0.09%，年初至今跌5.16%，过去60日涨44.53%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729123039a6c71872&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729123039a6c71872&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2554131637","title":"Neurogene Inc.7月25日成交额为171.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554131637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554131637?lang=zh_cn&edition=full","pubTime":"2025-07-26 12:26","pubTimestamp":1753504005,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Neurogene Inc.成交额为171.83万美元，成交额较昨日减少21.83%，当日成交量为7.56万股。Neurogene Inc.于2025年7月25日跌0.39%，报22.72美元，该股过去5个交易日涨1.7%，年初至今跌0.61%，过去60日涨74.37%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726122653a464466c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726122653a464466c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2554275332","title":"Neurogene Inc.7月24日成交额为219.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554275332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554275332?lang=zh_cn&edition=full","pubTime":"2025-07-25 12:18","pubTimestamp":1753417123,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，Neurogene Inc.成交额为219.82万美元，成交额较昨日减少41.44%，当日成交量为9.64万股。Neurogene Inc.于2025年7月24日跌1.21%，报22.81美元，该股过去5个交易日涨0.93%，年初至今跌0.22%，过去60日涨57.31%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725121850a46281a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725121850a46281a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2553329681","title":"Neurogene Inc.7月22日成交额为247.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553329681","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553329681?lang=zh_cn&edition=full","pubTime":"2025-07-23 12:19","pubTimestamp":1753244340,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Neurogene Inc.成交额为247.62万美元，成交额较昨日减少4.16%，当日成交量为11.40万股。Neurogene Inc.于2025年7月22日涨1.29%，报21.94美元，该股过去5个交易日涨2.19%，年初至今跌4.02%，过去60日涨42.75%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723121910a45deb0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723121910a45deb0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2553289622","title":"Neurogene Inc.7月21日成交额为258.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553289622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553289622?lang=zh_cn&edition=full","pubTime":"2025-07-22 12:15","pubTimestamp":1753157738,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，Neurogene Inc.成交额为258.36万美元，成交额较昨日增加1.99%，当日成交量为11.63万股。Neurogene Inc.于2025年7月21日跌3.04%，报21.66美元，该股过去5个交易日跌2.7%，年初至今跌5.25%，过去60日涨40.28%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722121544a6b9be16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722121544a6b9be16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2552545948","title":"Neurogene Inc.7月17日成交额为308.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552545948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552545948?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:12","pubTimestamp":1752811931,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Neurogene Inc.成交额为308.81万美元，成交额较昨日增加55.18%，当日成交量为13.51万股。Neurogene Inc.于2025年7月17日涨0.27%，报22.6美元，该股过去5个交易日涨2.91%，年初至今跌1.14%，过去60日涨88.02%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121215a45280b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121215a45280b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2551114923","title":"Neurogene Inc.7月15日成交额为304.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551114923","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551114923?lang=zh_cn&edition=full","pubTime":"2025-07-16 12:19","pubTimestamp":1752639561,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，Neurogene Inc.成交额为304.41万美元，成交额较昨日减少30.11%，当日成交量为14.29万股。Neurogene Inc.于2025年7月15日跌3.55%，报21.47美元，该股过去5个交易日涨5.87%，年初至今跌6.08%，过去60日涨99.35%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716121923a6ac89e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716121923a6ac89e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2551153955","title":"Neurogene Inc.7月14日成交额为435.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551153955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551153955?lang=zh_cn&edition=full","pubTime":"2025-07-15 12:17","pubTimestamp":1752553060,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Neurogene Inc.成交额为435.55万美元，成交额较昨日增加77.36%，当日成交量为20.11万股。Neurogene Inc.于2025年7月14日涨3.87%，报22.26美元，该股过去5个交易日涨14.15%，年初至今跌2.62%，过去60日涨95.95%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715121745a44b5e1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715121745a44b5e1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2550769106","title":"Neurogene Inc.7月9日成交额为483.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550769106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550769106?lang=zh_cn&edition=full","pubTime":"2025-07-10 12:16","pubTimestamp":1752121014,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Neurogene Inc.成交额为483.03万美元，成交额较昨日增加144.59%，当日成交量为22.92万股。Neurogene Inc.于2025年7月9日涨4.83%，报21.26美元，该股过去5个交易日涨10.79%，年初至今跌7.0%，过去60日涨137.01%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710121657a441aea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710121657a441aea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2550501070","title":"Neurogene Inc.7月8日成交额为197.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550501070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550501070?lang=zh_cn&edition=full","pubTime":"2025-07-09 12:14","pubTimestamp":1752034442,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Neurogene Inc.成交额为197.48万美元，成交额较昨日减少55.27%，当日成交量为9.73万股。Neurogene Inc.于2025年7月8日涨4.0%，报20.28美元，该股过去5个交易日涨35.65%，年初至今跌11.29%，过去60日涨124.58%。它正在为具有高度未满足需求的罕见神经系统疾病构建差异化的遗传药物产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709121413a69e8173&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709121413a69e8173&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurogene.com","stockEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0467},{"period":"3month","weight":0.1229},{"period":"6month","weight":0.2382},{"period":"1year","weight":-0.1697},{"period":"ytd","weight":-0.1247}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neurogene Inc.前身为6175813加拿大公司（6175813 Canada Inc.）。该公司根据加拿大商业公司法，于2003年12月26日注册成立。Neurogene的使命是治疗毁灭性的神经系统疾病，以改善受这些罕见疾病影响的患者和家庭的生活。Neurogene正在开发新的方法和治疗方法，以解决传统基因疗法在中枢神经系统疾病中的局限性。这包括选择一种递送方法以最大限度地分配到目标组织，并设计产品以最大限度地提高效力和纯度，以实现优化的功效和安全性。Neurogene的新型专有EXACT转基因调控平台技术允许传递治疗水平，同时限制与常规基因治疗相关的转基因毒性。Neurogene在德克萨斯州休斯顿建造了一座最先进的基因疗法制造设施。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.051789},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.050266},{"month":3,"riseRate":0.454545,"avgChangeRate":0.037124},{"month":4,"riseRate":0.25,"avgChangeRate":-0.076909},{"month":5,"riseRate":0.5,"avgChangeRate":0.000899},{"month":6,"riseRate":0.416667,"avgChangeRate":-0.072235},{"month":7,"riseRate":0.5,"avgChangeRate":-0.055031},{"month":8,"riseRate":0.833333,"avgChangeRate":0.776521},{"month":9,"riseRate":0.25,"avgChangeRate":-0.065331},{"month":10,"riseRate":0.416667,"avgChangeRate":0.020322},{"month":11,"riseRate":0.416667,"avgChangeRate":0.000025},{"month":12,"riseRate":0.583333,"avgChangeRate":0.145155}],"exchange":"NASDAQ","name":"NEUROGENE INC","nameEN":"NEUROGENE INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NEUROGENE INC,NGNE,NEUROGENE INC股票,NEUROGENE INC股票老虎,NEUROGENE INC股票老虎国际,NEUROGENE INC行情,NEUROGENE INC股票行情,NEUROGENE INC股价,NEUROGENE INC股市,NEUROGENE INC股票价格,NEUROGENE INC股票交易,NEUROGENE INC股票购买,NEUROGENE INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}